Jack W. Singer
2013
In 2013, Jack W. Singer earned a total compensation of $1.4M as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 22% increase compared to previous year.
Compensation breakdown
| Bonus | $203,500 |
|---|---|
| Option Awards | $284,940 |
| Salary | $347,500 |
| Stock Awards | $493,158 |
| Other | $38,502 |
| Total | $1,367,600 |
Singer received $493.2K in stock awards, accounting for 36% of the total pay in 2013.
Singer also received $203.5K in bonus, $284.9K in option awards, $347.5K in salary and $38.5K in other compensation.
Rankings
In 2013, Jack W. Singer's compensation ranked 5,315th out of 12,286 executives tracked by ExecPay. In other words, Singer earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,315 out of 12,286 | 57th |
Division Manufacturing | 1,840 out of 4,612 | 60th |
Major group Chemicals And Allied Products | 526 out of 1,466 | 64th |
Industry group Drugs | 376 out of 1,160 | 68th |
Industry Pharmaceutical Preparations | 300 out of 890 | 66th |
Source: SEC filing on March 17, 2016.
Singer's colleagues
We found four more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2013.